172 related articles for article (PubMed ID: 3499167)
1. Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura.
Murphy WG; Moore JC; Barr RD; Pai MK; Kelton JG
Br J Haematol; 1987 Aug; 66(4):509-13. PubMed ID: 3499167
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
3. Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission.
Chintagumpala MM; Hurwitz RL; Moake JL; Mahoney DH; Steuber CP
J Pediatr; 1992 Jan; 120(1):49-53. PubMed ID: 1731024
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic thrombocytopenic purpura: recovery after splenectomy associated with persistence of abnormally large von Willebrand factor multimers.
Rowe JM; Francis CW; Cyran EM; Marder VJ
Am J Hematol; 1985 Oct; 20(2):161-8. PubMed ID: 3876029
[TBL] [Abstract][Full Text] [Related]
5. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
7. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
8. Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura.
Moake JL; Byrnes JJ; Troll JH; Rudy CK; Hong SL; Weinstein MJ; Colannino NM
Blood; 1985 May; 65(5):1232-6. PubMed ID: 3873262
[TBL] [Abstract][Full Text] [Related]
9. The detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura.
Kelton JG; Moore J; Santos A; Sheridan D
Ann Intern Med; 1984 Nov; 101(5):589-93. PubMed ID: 6333196
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor in the pathophysiology of thrombotic thrombocytopenic purpura.
Moake JL
Clin Lab Sci; 1998; 11(6):362-4. PubMed ID: 10345504
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons.
Feys HB; Roodt J; Vandeputte N; Pareyn I; Mottl H; Hou S; Lamprecht S; Van Rensburg WJ; Deckmyn H; Vanhoorelbeke K
Blood; 2012 Oct; 120(17):3611-4. PubMed ID: 22855603
[TBL] [Abstract][Full Text] [Related]
12. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission.
Lotta LA; Lombardi R; Mariani M; Lancellotti S; De Cristofaro R; Hollestelle MJ; Canciani MT; Mannucci PM; Peyvandi F
J Thromb Haemost; 2011 Sep; 9(9):1744-51. PubMed ID: 21726405
[TBL] [Abstract][Full Text] [Related]
13. [Multimeric composition of von Willebrand factor in thrombotic thrombocytopenic purpura. Japanese TTP Study Group].
Tatewaki W
Nihon Rinsho; 1993 Jan; 51(1):146-50. PubMed ID: 8433508
[TBL] [Abstract][Full Text] [Related]
14. Interactions of von Willebrand factor and ADAMTS13 in von Willebrand disease and thrombotic thrombocytopenic purpura.
Budde U; Schneppenheim R
Hamostaseologie; 2014; 34(3):215-25. PubMed ID: 25010251
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura.
Karpman D; Lethagen S; Kristoffersson A; Isaksson C; Holmberg L
Thromb Haemost; 1997 Dec; 78(6):1456-62. PubMed ID: 9423794
[TBL] [Abstract][Full Text] [Related]
17. Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
Galbusera M; Benigni A; Paris S; Ruggenenti P; Zoja C; Rossi C; Remuzzi G
J Am Soc Nephrol; 1999 Jun; 10(6):1234-41. PubMed ID: 10361861
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
Moake JL
Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay.
Casonato A; Fabris F; Pontara E; Cattini MG; Zocca N; Gallinaro L; Girolami A; Pagnan A
Clin Appl Thromb Hemost; 2006 Jul; 12(3):296-304. PubMed ID: 16959682
[TBL] [Abstract][Full Text] [Related]
20. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
